Global Anticoagulant Market Growth 2025-2031
Description
The global Anticoagulant market size is predicted to grow from US$ 2869 million in 2025 to US$ 4170 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
LP Information, Inc. (LPI) ' newest research report, the “Anticoagulant Industry Forecast” looks at past sales and reviews total world Anticoagulant sales in 2024, providing a comprehensive analysis by region and market sector of projected Anticoagulant sales for 2025 through 2031. With Anticoagulant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anticoagulant industry.
This Insight Report provides a comprehensive analysis of the global Anticoagulant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anticoagulant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anticoagulant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anticoagulant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anticoagulant.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulant market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral
Injectable
Segmentation by Application:
DVT
PE
AF
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anticoagulant market?
What factors are driving Anticoagulant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anticoagulant market opportunities vary by end market size?
How does Anticoagulant break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
LP Information, Inc. (LPI) ' newest research report, the “Anticoagulant Industry Forecast” looks at past sales and reviews total world Anticoagulant sales in 2024, providing a comprehensive analysis by region and market sector of projected Anticoagulant sales for 2025 through 2031. With Anticoagulant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anticoagulant industry.
This Insight Report provides a comprehensive analysis of the global Anticoagulant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anticoagulant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anticoagulant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anticoagulant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anticoagulant.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulant market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral
Injectable
Segmentation by Application:
DVT
PE
AF
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anticoagulant market?
What factors are driving Anticoagulant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anticoagulant market opportunities vary by end market size?
How does Anticoagulant break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
105 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Anticoagulant by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Anticoagulant by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
